Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Göran Roos

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Biochimica Et Biophysica Acta|May 8, 2009
Telomere length as a biological marker in malignancyUlrika Svenson, Göran Roos
Lakartidningen|March 26, 2010
[The Nobel Prize on the protective function of telomeres can be very useful clinically. Several research targets ahead--not only new cancer therapies]Göran Roos, Pia Osterman
Blood|October 27, 2019
Response: Or both?Göran Roos, Richard Rosenquist, Stephan Stilgenbauer
Leukemia & Lymphoma|August 13, 2009
Thymidylate synthase polymorphism relevant for survival in patients with diffuse large B-cell lymphoma?Mattias Berglund, Göran Roos, Ulf Thunberg
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 23, 2017
Long leukocyte telomere length in prostate cancer patients at diagnosis is associated with poor metastasis-free and cancer-specific survivalUlrika Svenson, Göran Roos, Pernilla Wikström
Cancer Research|March 26, 2009
Telomere length in peripheral blood predicts survival in clear cell renal cell carcinomaUlrika Svenson, Börje Ljungberg, Göran Roos
International Journal of Cancer|January 30, 2004
Retinoblastoma protein in human renal cell carcinoma in relation to alterations in G1/S regulatory proteinsYlva Hedberg, Börje Ljungberg, Göran Roos, et al.
Acta Oncologica (Stockholm, Sweden)|July 10, 2002
Cyclin D3 protein content in human renal cell carcinoma in relation to cyclin D1 and clinico-pathological parametersYlva Hedberg, Göran Roos, Börje Ljungberg, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 4, 2014
Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carcinomaLinda Köhn, Ulrika Svenson, Börje Ljungberg, et al.
Experimental Hematology|October 18, 2002
Minimal residual disease quantification in childhood acute lymphoblastic leukemia by real-time polymerase chain reaction using the SYBR green dyeAi-Hong Li, Erik Forestier, Richard Rosenquist, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Biochimica Et Biophysica Acta|May 8, 2009
Telomere length as a biological marker in malignancyUlrika Svenson, Göran Roos
Lakartidningen|March 26, 2010
[The Nobel Prize on the protective function of telomeres can be very useful clinically. Several research targets ahead--not only new cancer therapies]Göran Roos, Pia Osterman
Blood|October 27, 2019
Response: Or both?Göran Roos, Richard Rosenquist, Stephan Stilgenbauer
Leukemia & Lymphoma|August 13, 2009
Thymidylate synthase polymorphism relevant for survival in patients with diffuse large B-cell lymphoma?Mattias Berglund, Göran Roos, Ulf Thunberg
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 23, 2017
Long leukocyte telomere length in prostate cancer patients at diagnosis is associated with poor metastasis-free and cancer-specific survivalUlrika Svenson, Göran Roos, Pernilla Wikström
Cancer Research|March 26, 2009
Telomere length in peripheral blood predicts survival in clear cell renal cell carcinomaUlrika Svenson, Börje Ljungberg, Göran Roos
International Journal of Cancer|January 30, 2004
Retinoblastoma protein in human renal cell carcinoma in relation to alterations in G1/S regulatory proteinsYlva Hedberg, Börje Ljungberg, Göran Roos, et al.
Acta Oncologica (Stockholm, Sweden)|July 10, 2002
Cyclin D3 protein content in human renal cell carcinoma in relation to cyclin D1 and clinico-pathological parametersYlva Hedberg, Göran Roos, Börje Ljungberg, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 4, 2014
Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carcinomaLinda Köhn, Ulrika Svenson, Börje Ljungberg, et al.
Experimental Hematology|October 18, 2002
Minimal residual disease quantification in childhood acute lymphoblastic leukemia by real-time polymerase chain reaction using the SYBR green dyeAi-Hong Li, Erik Forestier, Richard Rosenquist, et al.
Pageof 10